Source: Medistem Laboratories, Inc. via Yahoo! News
Posted: Tuesday May 23, 2006 4:01 pm ET
Summary:
Medistem Laboratories, Inc. committed to the ethical development medical therapies from non-controversial adult stem cells, announced today its filing of a U.S. patent application for an innovative cellular technology to treat lower back ailments by addressing causal issues and developing methodologies to prevent disc degeneration. The discovery relates to the administration of one or more cell types to stimulate lumbar angiogenesis, decrease inflammation, and stimulate regeneration. The therapy could be used to treat lower back ailments associated with disc degeneration.
Commentary: Hopefully this treatment will improve the quality of life for sufferers of lower back pain and disc damage or injury.
No comments:
Post a Comment